NKE · Nike, Inc.

Current Thesis

NIKE's turnaround thesis requires the 2026-10-01 earnings report to confirm gross-margin expansion and preserve its fiscal 2027 revenue outlook before a weekly close below $36 invalidates the recovery case. That is a conditional recovery thesis: the 2026-09-11 adjusted close of $36.80 and three-month price decline of 17.2% provide no confirmation that it has begun.

The material change since September 3 is BMO Capital's Underperform initiation with a $30 analyst price target, reported by The Fly on 2026-09-08. BMO expects the October report to reset fiscal 2027 expectations, citing weaker lifestyle demand, China's distribution reset and lower margins. Those are BMO's forecasts, rather than company guidance. The Fly's BMO report.

The inference remains that the narrative is dead — the established turnaround story has no price confirmation in the 2026-09-11 decline, while BMO's September initiation extends the adverse estimate debate. This classification would change if October's operating results satisfy the recovery test and price avoids the published weekly-close invalidation.

Bullish and bearish views on Nike, Inc.

The model's bull view on Nike, Inc. (NKE), in brief: Margin improvement has a test. Management's June 2026 outlook, documented in the September 3 research, called for gross-margin expansion beginning in the first quarter of fiscal 2027. Expansion in the 2026-10-01 results would support that operating claim; flat or declining gross… The bear view: A lower analyst valuation arrives. BMO's $30 price target, reported on 2026-09-08, introduces a valuation below the 2026-09-11 adjusted close of $36.80. Its expectation of a fiscal 2027 reset remains unconfirmed until company reporting. The Fly's BMO report. Earnings… Both cases follow in full.

Bull Case

• Margin improvement has a test. Management's June 2026 outlook, documented in the September 3 research, called for gross-margin expansion beginning in the first quarter of fiscal 2027. Expansion in the 2026-10-01 results would support that operating claim; flat or declining gross margin would refute it.
• Momentum already reflects substantial weakness. The adjusted market series dated 2026-09-11 shows a 14-day relative strength index (RSI) of 26.4 and a price 49.0% below its 52-week high. These observations establish weak momentum; they do not establish a reversal or its probability.

Bear Case

• A lower analyst valuation arrives. BMO's $30 price target, reported on 2026-09-08, introduces a valuation below the 2026-09-11 adjusted close of $36.80. Its expectation of a fiscal 2027 reset remains unconfirmed until company reporting. The Fly's BMO report.
• Earnings expectations were already weakening. Benzinga's 2026-08-31 report put JPMorgan's fiscal 2027 earnings-per-share estimate at $1.55 against contemporaneous consensus of $1.72, with annual revenue expected to decline. That comparison describes the August estimate gap; an updated consensus figure is missing.

Setup & Price Structure

The measured reference is the 2026-09-11 split- and dividend-adjusted close of $36.80. The same dated series reports a $72.19 52-week high and a three-month decline of 17.2%. Moving-average values, trading volume and short-interest measurements are missing, so neither distance from a rising average nor crowded short positioning can be established.

The $36 weekly-close threshold defines failure of the prospective recovery case. It is a research boundary; the available price snapshot does not establish a support shelf there. Low RSI alone supplies no evidence that selling has finished.

A concrete positioning event precedes earnings: S&P Dow Jones Indices announced on 2026-09-04 that NIKE will leave the S&P 100 before trading opens on 2026-09-21. The announcement establishes an index-membership change, but supplies no measured fund-flow amount or evidence that any resulting price pressure remains ahead. S&P Dow Jones Indices announcement.

Catalyst Calendar (next 30 days)

• 2026-09-21 — S&P 100 removal. The change takes effect before the market opens, according to the index provider's 2026-09-04 announcement. This dates the index event separately from the operating report. Index announcement.
• 2026-10-01 — First-quarter fiscal 2027 results. NIKE's 2026-08-28 announcement schedules results at approximately 1:15 p.m. Pacific Time and the management call at 2:00 p.m. Pacific Time. The recovery test is reported gross-margin expansion and preservation of the fiscal 2027 revenue outlook; a margin contraction or lower outlook would contradict it. NIKE earnings announcement.

What Would Change Our Mind

Failure to establish a trough ends the price-recovery case: a weekly close below $36 is the observable invalidation, measured using adjusted daily bars. The 2026-09-11 close of $36.80 remains above that boundary, without establishing a base.

The operating case would strengthen if the 2026-10-01 report delivers year-over-year gross-margin expansion and preserves the fiscal 2027 revenue outlook before that price boundary is breached. Conversely, flat or falling gross margin, or a reduced revenue outlook, would defeat the specified earnings-confirmation test. The evidence supports low conviction in that recovery outcome, rather than a forecast that BMO's target will be reached.

Correlation Notes

NIKE remains a single-company turnaround case. Benzinga reported on 2026-08-25 that NIKE declined alongside disappointing Dick's Sporting Goods results, and its 2026-09-04 coverage identified Lululemon margin pressure. These dated observations suggest a shared athletic-apparel demand exposure, but the sample is too small to support a statistical correlation claim or a forecast of a group recovery.